This will likely impact this market, but with the potential upside that BMI reductions due to GLP-1s may take more patients into the indicated weight range for bariatric devices
You Finally Understand GLP-1s Now Lets Talk About Reality GLP-1 medications like semaglutide and tirzepatide have changed the conversation around weight lossand for good reason
nonetheless, significant factors must be considered for patient selection and monitoring
T2D, non-alcoholic fatty liver disease (also known as metabolic dysfunction-associated steatotic liver disease) and hypertension diagnoses were all associated with lower weight loss efficacy, consistent with previous reports 22,23,24
By influencing appetite and reducing caloric intake, Ozempic helps patients manage their weight
Figure 1 Incretin action plays a large role on post-prandial secretion of insulin, and may account for up to 70% of hormone release (6)